The first bladder transplant in a living patient is the successful result of years of research and surgical innovation.

In this study, the cytotoxic potential ruthenium (II) complex containing 3,4-methylenedioxy cinnamic acid (CINNAM) was evaluated against nonsmall cell lung cancer (NSCLC) cell lines with different ...

Sugemalimab with chemotherapy showed a superior long-term overall survival benefit compared with placebo with chemotherapy, as a first-line treatment for patients with NSCLC with no known sensitising ...